ALT, AST, GGT, and the prevalence of NAFLD were significantly high in order of MS group, Pre-MS group, Non-MS group (p < 0.05, p <0.05, p <0.05, and p <0.001, respectively). This evidence concerns the gene GPT and myeloid sarcoma.